GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NeuPath Health Inc (TSXV:NPTH) » Definitions » Capital Expenditure

NeuPath Health (TSXV:NPTH) Capital Expenditure : C$-0.80 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is NeuPath Health Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

NeuPath Health's cash flow for capital expenditures for the three months ended in Sep. 2024 was C$-0.20 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.80 Mil.

NeuPath Health Capital Expenditure Historical Data

The historical data trend for NeuPath Health's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuPath Health Capital Expenditure Chart

NeuPath Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
-0.13 -0.10 -0.75 -1.67 -0.35

NeuPath Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.12 -0.05 -0.43 -0.20

NeuPath Health Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeuPath Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NeuPath Health Inc (TSXV:NPTH) » Definitions » Capital Expenditure
Comparable Companies
TSXV:JNH TSXV:NLH TSXV:ELM TSXV:PHA TSXV:KDA TSX:NUMI HCA SZSE:300015 SAU:4013 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS CHE NSE:APOLLOHOSP AGL ASX:RHC
Traded in Other Exchanges
N/A
Address
181 Bay Street, Suite 2100, Toronto, ON, CAN, M5J 2T3
Website
https://www.neupath.com
NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.
Executives
Daniel Chicoine Director
Joseph Andrew Walewicz Director
Daniel Marcel Legault Director
Grishanth Ram Ram Director
Grant Connelly Senior Officer
Stephen Lemieux Senior Officer

NeuPath Health Headlines

No Headlines